AXNX stock: buy or sell?

AXNX stock price: $38.84 0.49% At close on May 22nd, 2020

Updated on:
May 22nd, 2020


Axonics Modulation shares grew 0.49% to $38.84 on May/22. On Monday AXNX boosted an extraordinary 6.40%.

Should I buy AXNX stock?

Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. That's why is so important to choose your own trading plan that matches with your character as inversor. There are thousands of trading strategies for you to choose, but at we prefer those that are simple but successful.

None of our preferred buy setups matches with Axonics Modulation Technologies stock situation right now, hence this is not a suitable entry point.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean AXNX will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Axonics Modulation stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. Unfortunately, we couldn't find any rating for AXNX stock for the last month.

AXNX stock analysis

Daily outlook

Axonics Modulation Technologies grew a tiny 0.49% and closed at $38.84.

Axonics Modulation Technologies grew a tiny 0.49% and closed at $38.84. Since SMA100d and SMA200d crossed up on Apr/28, AXNX price climbed $3.96 per share (11.35%). Since last Apr 15th when AXNX stock price broke up the SMA200d line, it gained $9.59 (32.79%).

AXNX stock chart (daily)

Weekly outlook

Shares of Axonics Modulation Technologies closed this week at $38.84 and rocketed an outstanding 8.46%. Late April AXNX plummed a scary -12.10% in just one week. For 3 weeks in a row, price soared and marked a profit of 22.02%.

The downtrend marked by AXNX has left consecutive falling tops and bottoms. There is an opportunity to rebound and reverse this situation if price can hold above the level. Late April, SMA20w and SMA40w crossed up triggering a rise of 13.20%. Since mid April when AXNX stock price broke up the SMA40w line, it gained $10.50 (37.05%). Far behind is the all-time high Axonics Modulation hit early July and since then the price is -10.45% below that top.

AXNX stock chart (weekly)

AXNX stock price history

AXNX stock went public on October 31st, 2018 with a price of $16.051. Since then, AXNX stock grew a 142.00%, with a yearly average of 142.00%. If you had invested right after AXNX's IPO a $1,000 in AXNX stock in 2018, it would worth $1,420.00 today.

1: Adjusted price after possible price splits or reverse-splits.

AXNX stock historical price chart

AXNX stock reached all-time highs on July with a price of $43.37.

AXNX stock price target

Nobody can reliably foresee how stock prices may evolve in the future. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we have not found any price prediction for Axonics Modulation stock by any trusted analyst.

Financials and fundamental analysis

Earnings date and Earnings per Share

Axonics Modulation reported super good results for 2018-Q4 . Axonics Modulation Technologies rocketed Earnings per Share (EPS) by 56.30%, beating analysts estimates of $-0.32. Axonics Modulation Technologies posted $-0.50.
AXNX earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise

Annual financial results

Compared to 2017, last anual revenues report draw an outstanding gain of 452.34% to $0.71 million USD. When comparing 2018 vs 2017, aligned with this, profit margin (that is, the net income divided by revenues) climbed a 9,054.32% to -4,596.46%.

AXNX annual Sales and Income evolution
2017$0.13 M-$-17.47 M-13650.8%-
2018$0.71 M452.34%$-32.50 M-4596.5%85.98%

Quarterly financial results

Axonics Modulation posted $0.49 million in sales for 2018-Q4, a 145.77% up compared to previous quarter. Reported quarter income marked $-9.68 million with a profit margin of -1,958.50%. Profit margin skyrocketed a 1,806.17% compared to previous quarter when profit margin was -3,764.68%. When comparing sales to same quarter last year, Axonics Modulation Technologies sales marked a dazzling increase and boosted a inf%. Looking back to recent quarterly results, Axonics Modulation Technologies posted 2 negative quarters in a row.
AXNX quarterly Sales and Income evolution
2017-Q3$0.13 M-$-4.00 M-3127.3%-
2018-Q3$0.20 M57.03%$-7.57 M-3764.7%89.03%
2018-Q4$0.49 M145.77%$-9.68 M-1958.5%27.86%

Axonics Modulation ownership

When you are planning to buy a stock, it's always worth to overview its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Axonics Modulation Technologies, 9.90% of all outstanding shares are owned by its staff.

Bearish positions for AXNX stock account 0.00%, no big difference from last month.

For a better context understanding, the next table shows ownership data compared to other related stocks:

Market cap$1.3 B
Total shares34.5 M
Float shares19.3 M
  - Institutional holdings (%)102.8%
  - Insider holdings (%)9.9%
Shares in short selling0.0%

AXNX summary

Friday, May 22nd, 2020
Day range$37.51 - $39.08
Previous close$38.65
Session gain0.49%
Average true range$2.15
50d mov avg$29.57
100d mov avg$30.75
200d mov avg$28.86
Daily pattern
Weekly pattern lt02a

Axonics Modulation performance

Stocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Axonics Modulation, the comparison is made against .
AXNXAxonics Modulatio...7.62%75.59%22.91%

Axonics Modulation competitors

Unfortunately, we could not find any public company that could be defined as Axonics Modulation competitor. This doesn't mean Axonics Modulation does not have any competitor in the market, it's just we could not detected it.